Author

Ariful Islam

Daffodil International UniversityPrimary ORCID profile (0000-0001-7497-3540 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Ariful IslamiD1 paper · North South University

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Alexey GurevichiD· 1 shared David P. CormodeiD· 1 shared Kathleen Elizabeth Villaseñor· 1 shared Luis VazqueziD· 1 shared Md. Abul BasariD· 1 shared Md. Faruk HoseniD· 1 shared Mohammad Sarwar Hossain MollahiD· 1 shared Muhammad Shahin UddiniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexey GurevichORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Quantifying the Provenance-to-Function Gap in Antidiabetic Peptide Prediction: Homology-Aware Evaluation and the ADP-Hybrid Baseline

Ariful ISLAM, Md. Faruk Hosen, Md. Abul Basar, Mohammad Sarwar Hossain Mollah, Muhammad Shahin Uddin

The paper evaluates the provenance-to-function gap in antidiabetic peptide prediction by re-evaluating benchmarks with homologous peptide grouping and introduces the ADP-Hybrid baseline classifier.

bioRxiv · Oct 1, 2026 · PreprintBioinformatics

Drug-Eluting, Radiopaque, Tumor-Casting Hydrogels for Endovascular Locoregional Therapy of Hepatocellular Carcinoma

Yuxi C. Dong, Kathleen Elizabeth Villaseñor, Seokyoung Yoon, Ariful Islam, Luis Vazquez, Alexey Gurevich, Shaun W. McLaughlin, Terence P.F. Gade, David P. Cormode

This study develops a hydrogel for treating hepatocellular carcinoma that improves embolization and drug delivery, showing better tumor growth reduction than standard treatments.

bioRxiv · Nov 25, 2025 · PreprintCancer Biology